MEIRAGTX HOLDINGS

Summary

MeiraGTx is a vertically integrated, clinical-stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 25 M

Avg. Deal Size£ 25 M

Market Context

Senior Management

Alexandria Forbes
President CEO
Richard Giroux
CFO